Washington University in Saint Louis

Medical News Releases > Faculty Experts at Washington University in St. Louis >

Jeff Michalski

URL: http://mednews.wustl.edu/sb/page/normal/241.html

Media Assistance:

Gwen Ericson
Assistant Director of Research Communications
ericsong@wustl.edu
(314) 286-0141

Director, Siteman Cancer Center Clinical Trials Core

Expertise: adult and pediatric oncology, radiation oncology, radiation therapy, prostate conditions, prostate cancer, treatment planning, carcinoma of the prostate, conformal radiation therapy, prostate brachytherapy

Bio: Michalski is an associate professor of radiation oncology and an oncologist specializing in genitourinary and pediatric oncologist. He conducts clinical research on the use of radiation therapy for treatment of prostate and other cancers.

Education:


News Stories & Tip Sheets:

Showing 2 Stories.
'Excellent leader'

Jeff Michalski named interim head of Department of Radiation Oncology (http://mednews.wustl.edu/news/page/normal/11358.html)

March 21, 2008 --
Michalski
Jeff Michalski, professor of radiation oncology, has been named interim head of the Department of Radiation Oncology at Washington University School of Medicine in St. Louis, effective April 1. Michalski is replacing Simon Powell, who has taken a position as head of radiation oncology at Memorial-Sloan Kettering Cancer Center in New York.


Targeting treatment

New technologies add precision to prostate cancer treatments (http://mednews.wustl.edu/news/page/normal/10264.html)

Oct. 8, 2007 -- An extra degree of precision will be added to radiation treatments for prostate cancer at the School of Medicine following the installation of two new technologies in the Department of Radiation Oncology. The move to adopt these technologies was led by Jeff Michalski, professor of radiation oncology.



Showing 2 Stories.
Clips:

Showing 1 Clips.
Scientists decry decline in research funding
St. Louis Post-Dispatch and 10 others

March 20, 2007 -- In an era of bioterrorism, bird flu, an obesity epidemic and exploding health-care costs, the U.S. can ill-afford to reduce research funding, NIH supporters say.
But WUSTL cancer researcher Jeff Michalski and other scientists are finding that funds for adequate research are declining.
Michalski is director of radiation oncology at WUSTL Siteman Cancer Center.
On Monday, scientists from top universities testified before the U.S. Senate Appropriations subcommittee, which will help determine how much money the NIH gets for 2008, about how dire they think the situation is.
WUSTL medical school dean Larry Shapiro comments.



Related Information


Related Links:
•Michalski's Siteman Web page (http://www.siteman.wustl.edu/patient/about_phys/about_0127_pubs.shtml)
•Michalski's Radiation Oncology Web page (http://radonc.wustl.edu/michalski.html)

Related Groups: